Literature DB >> 29742422

A General Framework for Interrogation of mRNA Stability Programs Identifies RNA-Binding Proteins that Govern Cancer Transcriptomes.

Gabrielle Perron1, Pouria Jandaghi1, Shraddha Solanki2, Maryam Safisamghabadi1, Cristina Storoz2, Mehran Karimzadeh1, Andreas I Papadakis3, Madeleine Arseneault1, Ghislaine Scelo4, Rosamonde E Banks5, Jorg Tost6, Mark Lathrop1, Simon Tanguay7, Alvis Brazma8, Sidong Huang3, Fadi Brimo2, Hamed S Najafabadi9, Yasser Riazalhosseini10.   

Abstract

Widespread remodeling of the transcriptome is a signature of cancer; however, little is known about the post-transcriptional regulatory factors, including RNA-binding proteins (RBPs) that regulate mRNA stability, and the extent to which RBPs contribute to cancer-associated pathways. Here, by modeling the global change in gene expression based on the effect of sequence-specific RBPs on mRNA stability, we show that RBP-mediated stability programs are recurrently deregulated in cancerous tissues. Particularly, we uncovered several RBPs that contribute to the abnormal transcriptome of renal cell carcinoma (RCC), including PCBP2, ESRP2, and MBNL2. Modulation of these proteins in cancer cell lines alters the expression of pathways that are central to the disease and highlights RBPs as driving master regulators of RCC transcriptome. This study presents a framework for the screening of RBP activities based on computational modeling of mRNA stability programs in cancer and highlights the role of post-transcriptional gene dysregulation in RCC.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ESRP2; MBNL2; PCBP2; RNA-binding proteins; gene regulation; mRNA stability; network modeling; regulatory networks; renal cancer

Year:  2018        PMID: 29742422     DOI: 10.1016/j.celrep.2018.04.031

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  21 in total

1.  An RNA-binding protein-related risk signature can predict the prognosis and tumor immunity of patients with testicular germ cell tumors.

Authors:  Yang Fu; Shanshan Sun; Jianbin Bi; Chuize Kong; Du Shi
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 2.  RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease.

Authors:  Sophia Kelaini; Celine Chan; Victoria A Cornelius; Andriana Margariti
Journal:  Biology (Basel)       Date:  2021-04-24

3.  Integrated Analysis of RNA-Binding Proteins in Glioma.

Authors:  Zhixing Wang; Wanjun Tang; Jiangang Yuan; Boqin Qiang; Wei Han; Xiaozhong Peng
Journal:  Cancers (Basel)       Date:  2020-04-07       Impact factor: 6.639

4.  HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis.

Authors:  Marta Palomo-Irigoyen; Encarni Pérez-Andrés; Marta Iruarrizaga-Lejarreta; Adrián Barreira-Manrique; Miguel Tamayo-Caro; Laura Vila-Vecilla; Leire Moreno-Cugnon; Nagore Beitia; Daniela Medrano; David Fernández-Ramos; Juan José Lozano; Satoshi Okawa; José L Lavín; Natalia Martín-Martín; James D Sutherland; Virginia Guitiérez de Juan; Monika Gonzalez-Lopez; Nuria Macías-Cámara; David Mosén-Ansorena; Liyam Laraba; C Oliver Hanemann; Emanuela Ercolano; David B Parkinson; Christopher W Schultz; Marcos J Araúzo-Bravo; Alex M Ascensión; Daniela Gerovska; Haizea Iribar; Ander Izeta; Peter Pytel; Philipp Krastel; Alessandro Provenzani; Pierfausto Seneci; Ruben D Carrasco; Antonio Del Sol; María Luz Martinez-Chantar; Rosa Barrio; Eduard Serra; Conxi Lazaro; Adrienne M Flanagan; Myriam Gorospe; Nancy Ratner; Ana M Aransay; Arkaitz Carracedo; Marta Varela-Rey; Ashwin Woodhoo
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 5.  Intrinsic Regulatory Role of RNA Structural Arrangement in Alternative Splicing Control.

Authors:  Katarzyna Taylor; Krzysztof Sobczak
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

6.  Muscleblind-like 2 controls the hypoxia response of cancer cells.

Authors:  Sandra Fischer; Antonella Di Liddo; Katarzyna Taylor; Jamina S Gerhardus; Krzysztof Sobczak; Kathi Zarnack; Julia E Weigand
Journal:  RNA       Date:  2020-03-03       Impact factor: 4.942

7.  Integrated analysis of RNA-binding proteins in human colorectal cancer.

Authors:  Xuehui Fan; Lili Liu; Yue Shi; Fanghan Guo; Haining Wang; Xiuli Zhao; Di Zhong; Guozhong Li
Journal:  World J Surg Oncol       Date:  2020-08-22       Impact factor: 2.754

8.  Characterizing the interplay between gene nucleotide composition bias and splicing.

Authors:  Sébastien Lemaire; Nicolas Fontrodona; Fabien Aubé; Jean-Baptiste Claude; Hélène Polvèche; Laurent Modolo; Cyril F Bourgeois; Franck Mortreux; Didier Auboeuf
Journal:  Genome Biol       Date:  2019-11-29       Impact factor: 13.583

9.  Effects of RNA Binding Proteins on the Prognosis and Malignant Progression in Prostate Cancer.

Authors:  Xiaoliang Hua; Shengdong Ge; Juan Chen; Li Zhang; Sheng Tai; Chaozhao Liang
Journal:  Front Genet       Date:  2020-10-20       Impact factor: 4.599

10.  Molecular Characterization and Clinical Relevance of RNA Binding Proteins in Colorectal Cancer.

Authors:  Zhen Zhang; Ling Wang; Quan Wang; Mengmeng Zhang; Bo Wang; Kewei Jiang; Yingjiang Ye; Shan Wang; Zhanlong Shen
Journal:  Front Genet       Date:  2020-10-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.